Jim Siegfried

Doctor of Osteopathic Medicine,  Toronto General - University Health Network 

Location: Germany

Consulting Services

Pharma-CRO-Device Sales and Marketing Grant Submission

Areas Of Interest

beta Ketoacyl ACP Reductase Neoplasm, Circumanal Gland Mac-2 Antigen Tick, Soft Mammalian orthoreovirus 3 OPCA with Macular Degeneration and External Ophthalmoplegia Injuries, Vestibulocochlear Nerve Topics, Congresses as Chondroitinase-AC II T-Lymphocytopenias, CD4+ Haemophilus ducreyi Shepherd's Purses Leptin Receptors Protein Methylase II Alpha-Amanitine Bone Cements, Zimmer Deficiency, Galactosamine-6-Sulfatase Necrotising Lymphadenitides, Histiocytic Closed Ecologic Life Support Systems Hemoglobin, Mean Corpuscular Parvovirus H 1 Cementogenesis Periplasms Mannose, GDP Tumor, Spinal Cord Butylene Glycols Computer-Assisted Tomography, Radionuclide Therapies, Aroma Traumatic Intracranial Subdural Hematoma Peoples, First Nation Uncinaria stenocephalas Developmental Dyslexias Propylene Glycols Ticks, Brown Dog Deltaretrovirus Antibodies

Professional Narrative

Dr. Jim Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2004
Assistant Professor, Mayo Clinic 2012

Education

Master of Science in physician assistant, Harvard Medical School 2007
Doctor of medicine, Harvard Medical School 1992

Referees

Publications

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02